Home > PJ (current issue) > Leading article | Search

PJ Online homeThe Pharmaceutical Journal
Vol 276 No 7383 p30
14 January 2006

This article
Reprint   Photocopy

PDF 20K, Acrobat Reader

Leading Article

Investing for the future

Correspondents to The Journal towards the end of last year — and another last week (PJ, 7 January, p13) — raised a number of concerns about conducting medicines use reviews. The main anxiety was the time required to undertake them properly — 20 to 30 minutes per review seems not to be unusual.

This should not come as any surprise since undertaking any new activity takes longer in the first few months than it does, say, one year later.

An article in this issue by Angela Alexander, of the School of Pharmacy, University of Reading (p44 PDF (90K)), emphasises this point in a different way that goes some way to explaining why some pharmacists may be finding the whole process a bit of an uphill struggle.

Other than dispensing, she points out, medicines use review is the first service to be commissioned nationally from pharmacists, the first service to require accreditation of both pharmacists and pharmacy premises and the first service to demand a specified set of competencies. Nearly everything about MUR is new. (Her article is primarily directed at community pharmacists in England and Wales, although the situation is not dissimilar in Scotland.)

Dr Alexander also argues that the commissioning of future enhanced services could depend on the demonstrated success of providing an MUR service.

Dr Alexander also produces a SWOT (strengths, weaknesses, opportunities and threats) analysis of MURs drawn from the experiences of five groups of pharmacists who attended training sessions at the University of Reading (p45 PDF (90K)). There is a thread running through all four SWOT categories: communication. Communication underpins the success of this service and will underpin the successful development of all other services in the future.

Many people will have experienced the frustrations of waiting to see GP registrars (ie, ones in training) and discovering that their clinics over-run because they spend much longer with patients than do older hands. The registrars have not yet seen the patterns in the health carpet, to be able to anticipate lines of questioning and to reach diagnoses quickly and confidently. This process is not unlike the one pharmacists learning to conduct MURs successfully are experiencing.

Once pharmacists are more familiar with conducting MURs they will be able to complete them more quickly. Time spent learning skills now will be an investment for the future.

Back to Top


©The Pharmaceutical Journal